Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of AKR1B10 in Physiology and Pathophysiology
Satoshi Endo, Toshiyuki Matsunaga, Toru Nishinaka
Metabolites (2021) Vol. 11, Iss. 6, pp. 332-332
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis
Wenzhe Duan, Wenwen Liu, Shengkai Xia, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 36
MicroRNA-383: A tumor suppressor miRNA in human cancer
Abdollah Jafarzadeh, Majid Noori, Shaghayegh Sarrafzadeh, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 26
Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer
Christian Bailly
European Journal of Pharmacology (2022) Vol. 931, pp. 175191-175191
Closed Access | Times Cited: 23
Inflammatory liver diseases and susceptibility to sepsis
Hong Lü
Clinical Science (2024) Vol. 138, Iss. 7, pp. 435-487
Closed Access | Times Cited: 5
Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD
Sa Yang, Shijie Cao, Congyu Li, et al.
Journal of Ethnopharmacology (2024) Vol. 332, pp. 118354-118354
Closed Access | Times Cited: 5
The Potent Phytoestrogen 8-Prenylnaringenin: A Friend or a Foe?
Raimo Pohjanvirta, Atefeh Nasri
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3168-3168
Open Access | Times Cited: 22
METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10
Jingli Cai, Zheng Cui, Jingyi Zhou, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Machine learning-based algorithm identifies key mitochondria-related genes in non-alcoholic steatohepatitis
Longfei Dai, Renao Jiang, Zhicheng Zhan, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Nicotinate-curcumin improves NASH by inhibiting the AKR1B10/ACCα-mediated triglyceride synthesis
Xiu-Lian Lin, Yaling Zeng, Jie Ning, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids
Kanve N. Suvilesh, Yariswamy Manjunath, Yulia I. Nussbaum, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3855-3867
Closed Access | Times Cited: 4
Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse
Sangam Rajak, Pratima Gupta, Baby Anjum, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 4, pp. 166319-166319
Open Access | Times Cited: 24
A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease
Seung Joon Choi, Sungjin Yoon, Kyoung Kon Kim, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 4, pp. 740-751
Open Access | Times Cited: 4
In Search for Inhibitors of Human Aldo-Keto Reductase 1B10 (AKR1B10) as Novel Agents to Fight Cancer and Chemoresistance: Current State-of-the-Art and Prospects
Rosanna Maccari, Rosaria Ottanà
Journal of Medicinal Chemistry (2025)
Closed Access
Joint exploration of network pharmacology and metabolomics on the effects of traditional Chinese medicine compounds in weaned yaks
Sijia Lü, Yanbin Zhu, Xiaojuan Zhang, et al.
Frontiers in Veterinary Science (2025) Vol. 11
Open Access
Identification of potential metabolic biomarkers and immune cell infiltration for metabolic associated steatohepatitis by bioinformatics analysis and machine learning
Haoran Xie, Junjun Wang, Qiuyan Zhao
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
AKR1B10 regulates M2 macrophage polarization to promote the malignant phenotype of gastric cancer
Yi Wu, Yanjie Hao, Qing'xin Zhuang, et al.
Bioscience Reports (2023) Vol. 43, Iss. 10
Open Access | Times Cited: 9
Aldo-keto reductases: Role in cancer development and theranostics
Siddavaram Nagini, Prathap Reddy Kallamadi, Kranthi Kiran Kishore Tanagala, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 8, pp. 1287-1308
Open Access | Times Cited: 3
Iron overload exacerbates metabolic dysfunction-associated steatohepatitis via the microbiota-gut-liver axis through lipopolysaccharide-mediated Akr1b8 activation
Han Yu, Yuhui Zhang, Jianjun Chen, et al.
Free Radical Biology and Medicine (2025)
Closed Access
AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition
Xinyu Shao, Jue Wu, Shunying Yu, et al.
Aging (2021) Vol. 13, Iss. 18, pp. 22298-22314
Open Access | Times Cited: 20
Pirin, an Nrf2-Regulated Protein, Is Overexpressed in Human Colorectal Tumors
Ying Zhang, Elena V. Knatko, Maureen Higgins, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 262-262
Open Access | Times Cited: 14
AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome
Clovis Chabert, Anne-Laure Vitte, Domenico Iuso, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1911-1911
Open Access | Times Cited: 13
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study
Violeta Raverdy, Estelle Chatelain, Guillaume Lasailly, et al.
Obesity (2023) Vol. 31, Iss. 12, pp. 3066-3076
Open Access | Times Cited: 8
Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer
Amna Saeed, Syeda Abida Ejaz, Muhammad Sarfraz, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 3981-3981
Open Access | Times Cited: 11
Expression of AKRs superfamily and prognostic in human gastric cancer
Zhou Yujin, Yi Lin, Wenjing Li, et al.
Medicine (2023) Vol. 102, Iss. 8, pp. e33041-e33041
Open Access | Times Cited: 6
Phosphorylation of Metabolites Involved in Salvage Pathways for Isoprenoid Biosynthesis in Plants
Andréa Hemmerlin
Kinases and Phosphatases (2023) Vol. 1, Iss. 3, pp. 151-166
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top